Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13,424,543
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
2,353,724
-
Shares change
-
+966,513
-
Total reported value, excl. options
-
$56,868,048
-
Value change
-
+$22,987,380
-
Put/Call ratio
-
42%
-
Number of buys
-
40
-
Number of sells
-
-13
-
Price
-
$24.16
Significant Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) as of Q3 2025
66 filings reported holding TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share as of Q3 2025.
Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,353,724 shares
of 13,424,543 outstanding shares and own 17.53% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (681,530 shares), VANGUARD GROUP INC (556,957 shares), GEODE CAPITAL MANAGEMENT, LLC (200,934 shares), NORTHERN TRUST CORP (169,687 shares), STATE STREET CORP (152,544 shares), CAPITAL FUND MANAGEMENT S.A. (62,948 shares), MILLENNIUM MANAGEMENT LLC (52,731 shares), UBS Group AG (51,581 shares), FMR LLC (45,466 shares), and Susquehanna Portfolio Strategies, LLC (41,454 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.